Biotech | October 14, 2021
Sputnik Light has 70 % efficacy against infection with Delta: Gamaleya analysis
Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations
Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations
It has planned an investment of over Rs 80 crore in the next five years
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
New safety data show a consistent benefit-risk profile across all Ocrevus clinical trials
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
HCL will establish a joint centre of excellence (CoE) for Google Cloud with industry subject matter experts and Google Cloud-certified ideapreneurs
In Western Europe, about 2% of procedures are done robotically while the majority, approximately 65%, are open surgery
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
It is one of the first companies to launch a bioequivalent version of the dry powder inhaler and it's part of the company’s strategic exclusive in-licensing arrangement to market Tiotropium DPI in Western Europe and the UK
The first study to investigate the safety and immunogenicity of both vaccines when co-administered compared to each vaccine administered separately in adults aged 65 years and older
Subscribe To Our Newsletter & Stay Updated
